Funding for Medical Research
and Clinical Trials
and Clinical Trials
Funding Details for Heart
Use the contact information shown for the organization to apply for the funding.
Please notify CenTrial of any offer is incorrect or has expired.
Please notify CenTrial of any offer is incorrect or has expired.
Hearts Transplant
The International Society for Heart and Lung Transplantation (ISHLT)
Type of Organization: Foundation
Email Address: information@ishlt.org
Funds Available for Clinical Trials: ✔ Research: ✔
The Applicant must have completed a clinical or post-doctoral training program. Applications from new investigators are specifically invited.
The research project must be conducted at an accredited university, college, medical or dental school, School of Public Health, hospital, laboratory, or other non-profit institution.
No grants will be made for projects that receive overlapping funding from other sources (unless supplementary in nature) or that duplicate other projects already funded.
Other info: Purpose
The purpose of the Grant is to further the scientific understanding of the determinants of pediatric transplant heart longevity and thereby improve the quality and duration of life. Grants will be made for research proposals that have a high likelihood of being translated into clinical practice within five years and those that have relevance to or directly involve pediatric transplant recipients and/or their families.
Research Priorities
Funding decisions will be based upon scientific merit, innovation, application of new technologies, and alignment with one or more of the below areas of scientific interest relevant to improving heart transplant recipient longevity.
Evidence-based strategies for improving treatment adherence
Early and accurate identification of acute cellular and antibody-mediated rejection and cardiac allograft vasculopathy, including the development of accurate non-invasive methods and strategies for surveillance
Studies on the causes, prevention, and treatment of cardiac allograft vasculopathy
Research and development of novel immunotherapies, identification of novel targets, improving the side effect profiles of these agents as well as better monitoring and measurement of immunosuppression
Improving Organ Viability and Availability - strategies and innovations that would allow better organ matching and allocation and strategies and technologies to improve the availability and quality of donor hearts.
Development of strategies and studies aimed at new nutrition and exercise guidelines that improve the long-term outcomes of heart transplant recipients
Additional consideration will be given to applications that include clinical research or applications that include feasible clinical translations(s).
The International Society for Heart and Lung Transplantation (ISHLT)
Type of Organization: Foundation
Email Address: information@ishlt.org
Funds Available for Clinical Trials: ✔ Research: ✔
Funding Details
Requirements: The Applicant must be a member of the ISHLT in good standing at the time of application and throughout the period of funding.The Applicant must have completed a clinical or post-doctoral training program. Applications from new investigators are specifically invited.
The research project must be conducted at an accredited university, college, medical or dental school, School of Public Health, hospital, laboratory, or other non-profit institution.
No grants will be made for projects that receive overlapping funding from other sources (unless supplementary in nature) or that duplicate other projects already funded.
Other info: Purpose
The purpose of the Grant is to further the scientific understanding of the determinants of pediatric transplant heart longevity and thereby improve the quality and duration of life. Grants will be made for research proposals that have a high likelihood of being translated into clinical practice within five years and those that have relevance to or directly involve pediatric transplant recipients and/or their families.
Research Priorities
Funding decisions will be based upon scientific merit, innovation, application of new technologies, and alignment with one or more of the below areas of scientific interest relevant to improving heart transplant recipient longevity.
Evidence-based strategies for improving treatment adherence
Early and accurate identification of acute cellular and antibody-mediated rejection and cardiac allograft vasculopathy, including the development of accurate non-invasive methods and strategies for surveillance
Studies on the causes, prevention, and treatment of cardiac allograft vasculopathy
Research and development of novel immunotherapies, identification of novel targets, improving the side effect profiles of these agents as well as better monitoring and measurement of immunosuppression
Improving Organ Viability and Availability - strategies and innovations that would allow better organ matching and allocation and strategies and technologies to improve the availability and quality of donor hearts.
Development of strategies and studies aimed at new nutrition and exercise guidelines that improve the long-term outcomes of heart transplant recipients
Additional consideration will be given to applications that include clinical research or applications that include feasible clinical translations(s).